Wasatch Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,594,167
Closed -$21.9M 292
2021
Q3
$21.9M Sell
3,594,167
-591,278
-14% -$3.61M 0.09% 168
2021
Q2
$34.4M Sell
4,185,445
-26,001
-0.6% -$214K 0.14% 138
2021
Q1
$37.7M Buy
4,211,446
+101,952
+2% +$912K 0.17% 112
2020
Q4
$47.4M Buy
4,109,494
+500,773
+14% +$5.78M 0.23% 100
2020
Q3
$37.6M Sell
3,608,721
-57
-0% -$593 0.24% 101
2020
Q2
$47.5M Buy
3,608,778
+1,293,136
+56% +$17M 0.34% 87
2020
Q1
$18.2M Buy
2,315,642
+146,785
+7% +$1.16M 0.19% 100
2019
Q4
$44.9M Buy
2,168,857
+194,798
+10% +$4.03M 0.37% 79
2019
Q3
$27.1M Buy
1,974,059
+886,929
+82% +$12.2M 0.26% 91
2019
Q2
$13.4M Buy
1,087,130
+70,993
+7% +$873K 0.13% 123
2019
Q1
$12.7M Buy
1,016,137
+73,751
+8% +$920K 0.14% 113
2018
Q4
$10.7M Buy
942,386
+114,162
+14% +$1.29M 0.14% 107
2018
Q3
$15.5M Buy
828,224
+180,293
+28% +$3.37M 0.18% 93
2018
Q2
$16.7M Buy
647,931
+15,260
+2% +$394K 0.2% 90
2018
Q1
$14.2M Sell
632,671
-37,931
-6% -$850K 0.18% 92
2017
Q4
$16.8M Sell
670,602
-336,802
-33% -$8.43M 0.22% 87
2017
Q3
$24.4M Sell
1,007,404
-10,815
-1% -$262K 0.33% 78
2017
Q2
$20.6M Buy
1,018,219
+376,745
+59% +$7.62M 0.29% 79
2017
Q1
$17.3M Sell
641,474
-277,561
-30% -$7.47M 0.25% 80
2016
Q4
$17.5M Buy
919,035
+95,544
+12% +$1.82M 0.26% 82
2016
Q3
$16.1M Sell
823,491
-12,290
-1% -$240K 0.24% 96
2016
Q2
$12.5M Buy
835,781
+27,715
+3% +$415K 0.19% 116
2016
Q1
$7.27M Buy
808,066
+412,198
+104% +$3.71M 0.11% 161
2015
Q4
$7.63M Sell
395,868
-107,124
-21% -$2.06M 0.11% 176
2015
Q3
$7.47M Buy
502,992
+189,887
+61% +$2.82M 0.1% 186
2015
Q2
$6.85M Buy
+313,105
New +$6.85M 0.07% 220